Barclays’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
Other funds holding WVE
6CM
Barclays's WVE Position: Q3 2026 in Review
Barclays sold out of Wave Life Sciences (WVE) in Q3 2026, closing a stake of 309,580 shares — an estimated $1.8M sold.
Barclays first reported a position in WVE in Q2 2016 and held it in 39 quarters. The position peaked at $4.71M in Q4 2025. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.
- Barclays reported no remaining Wave Life Sciences position as of Q3 2026 after selling out during the quarter.
- Barclays sold 309,580 Wave Life Sciences shares in Q3 2026, an estimated $1.8M.
- Barclays first reported a position in Wave Life Sciences in Q2 2016 and held it in 39 quarters.
- Barclays's Wave Life Sciences position peaked at $4.71M in Q4 2025.
- 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.